Otofarma SpA (MIL:OTO) Asset Impairment Charge: €0.00 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:OTO Otofarma SpA MIL:OTO
18 GF Score
Price €2.40
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Asset Impairment Charge?

Otofarma SpA MIL:OTO +3.45% 18 Asset Impairment Charge is €0.00 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Asset Impairment Charge for the six months ended in Dec. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Otofarma SpA Asset Impairment Charge Related Terms

Otofarma SpA Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Asset Impairment Charge Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Asset Impairment Charge
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Asset Impairment Charge 0.00 0.00
MIL:OTO
18GF Score
Otofarma SpA MIL:OTO
Asset Impairment Charge is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

What does a Asset Impairment Charge of €0.00 Mil mean?
Otofarma SpA (MIL:OTO) has a Asset Impairment Charge of €0.00 Mil as of Dec. 2024.
Is Otofarma SpA's Asset Impairment Charge too high?
Otofarma SpA's current Asset Impairment Charge is €0.00 Mil. Overall, Otofarma SpA has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Asset Impairment Charge compare to ABT and SYK?
Otofarma SpA's Asset Impairment Charge of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Medical Devices & Instruments company?
A good Asset Impairment Charge depends on the Medical Devices & Instruments industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. Otofarma SpA's current Asset Impairment Charge is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Asset Impairment Charge of €0.00 Mil. The current Asset Impairment Charge is €0.00 Mil. Otofarma SpA's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Asset Impairment Charge is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
18GF Score

Get the complete analysis for MIL:OTO

Asset Impairment Charge is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.40
Price